Activating KRAS mutations (KRAS-mut), chromosome 18 deletions that include the DCC locus, and inactivation of the TGF-β response by SMAD2/SMAD4 changes are key steps in the development of adenomas. This evidence concerns the gene KRAS and adenoma.